Case report highlights ayurvedic intervention improving symptoms in a child with type-1 diabetes, suggesting potential benefits alongside insulin therapy.
Type-1 Diabetes Mellitus (T1DM) stands as a significant challenge in the modern world, accompanied by numerous complications. Conventional medicine primarily relies on injectable insulin to lower blood glucose levels in T1DM, but it has demonstrated limitations such as multiple pricks, insulin resistance, and long-term side effects. However, Ayurvedic approaches may serve as complementary strategies focused on improving metabolism, enhance quality of life, and offering supportive benefits in the comprehensive management of the condition. This case report presents the efficacy of Ayurveda management as an adjuvant with injectable insulin in a 12-year-old male child with TIDM, presenting with symptoms such as high blood sugar, increased urine frequency, excessive hunger, thirst, and general weakness. There was a significant reduction in objective criteria (laboratory investigations) and associated complaints within nine months of treatment. The subsequent follow-ups indicated sustained improvement, showcasing the effectiveness of Shamana chikitsa (~palliative therapy) along with conventional insulin therapy in managing TIDM, with no significant adverse effects. However, further researches as well as clinical trials are warranted to validate the findings and explore the broader applicability of Ayurveda interventions in diabetic care.
No takes yet. Share an insight, caveat, or question.
Mishra et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: